Gene and stem cell therapies

被引:69
作者
Kaji, EH
Leiden, JM
机构
[1] Abbott Labs, Dept Execut, Abbott Pk, IL 60064 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Vet Affairs Boston Healthcare Syst, Jamaica Plain, MA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 285卷 / 05期
关键词
D O I
10.1001/jama.285.5.545
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene and stem cell therapies hold promise for the treatment of a wide variety of inherited and acquired human diseases. Identification of genes involved in human disease and development of novel vectors and devices for delivering therapeutic genes to different tissues in vivo have resulted in significant progress in the area of gene therapy. Isolation of stem cells from organs formerly thought to have no regenerative potential, the demonstration of stem cell plasticity, and the creation of human embryonic stem cells clearly demonstrate the feasibility of human stem cell therapy. Much additional work remains to be done in the areas of vector development and stem cell biology before the full therapeutic potential of these approaches can be realized. Of equal importance, the ethical issues surrounding gene- and cell-based therapies must be confronted.
引用
收藏
页码:545 / 550
页数:6
相关论文
共 48 条
[1]  
[Anonymous], 2000, Nature, V405, P599
[2]   SYSTEMIC DELIVERY OF RECOMBINANT PROTEINS BY GENETICALLY MODIFIED MYOBLASTS [J].
BARR, E ;
LEIDEN, JM .
SCIENCE, 1991, 254 (5037) :1507-1509
[3]   Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source [J].
Beauchamp, JR ;
Morgan, JE ;
Pagel, CN ;
Partridge, TA .
JOURNAL OF CELL BIOLOGY, 1999, 144 (06) :1113-1121
[4]   An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer [J].
Binley, K ;
Iqball, S ;
Kingsman, A ;
Kingsman, S ;
Naylor, S .
GENE THERAPY, 1999, 6 (10) :1721-1727
[5]   Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo [J].
Bjornson, CRR ;
Rietze, RL ;
Reynolds, BA ;
Magli, MC ;
Vescovi, AL .
SCIENCE, 1999, 283 (5401) :534-537
[6]   Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts [J].
Bohl, D ;
Naffakh, N ;
Heard, JM .
NATURE MEDICINE, 1997, 3 (03) :299-305
[7]   Embryonic stem cell-derived glial precursors:: A source of myelinating transplants [J].
Brüstle, O ;
Jones, KN ;
Learish, RD ;
Karram, K ;
Choudhary, K ;
Wiestler, OD ;
Duncan, ID ;
McKay, RDG .
SCIENCE, 1999, 285 (5428) :754-756
[8]   Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].
Cavazzana-Calvo, M ;
Hacein-Bey, S ;
Basile, CD ;
Gross, F ;
Yvon, E ;
Nusbaum, P ;
Selz, F ;
Hue, C ;
Certain, S ;
Casanova, JL ;
Bousso, P ;
Le Deist, F ;
Fischer, A .
SCIENCE, 2000, 288 (5466) :669-672
[9]   CYTOSTATIC GENE-THERAPY FOR VASCULAR PROLIFERATIVE DISORDERS WITH A CONSTITUTIVELY ACTIVE FORM OF THE RETINOBLASTOMA GENE-PRODUCT [J].
CHANG, MW ;
BARR, E ;
SELTZER, J ;
JIANG, YQ ;
NABEL, GJ ;
NABEL, EG ;
PARMACEK, MS ;
LEIDEN, JM .
SCIENCE, 1995, 267 (5197) :518-522
[10]  
DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7